E-nitiate Biopharmaceuticals

company

About

E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
¥100M
Industries
Biopharma,Biotechnology,Health Care,Hospital
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥100M
E-nitiate Biopharmaceuticals has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Sep 15, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 15, 2022 Series A ¥100M 4 Momentum Venture Detail

Investors

Number of Lead Investors
Number of Investors
1
4
E-nitiate Biopharmaceuticals is funded by 4 investors. Momentum Venture and TaiKun Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Momentum Venture Yes Series A
TaiKun Fund Series A
Hangzhou Jintou Industrial Fund Series A
LPSCO Series A